Curtis Engelhart

8PUBLICATIONS
67CO-AUTHORS
Medical bacteriologyMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyComputational physiologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13.

Inna V Krieger, Paridhi Sukheja, Baiyuan Yang

|May 02, 2025
Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly.

Dietrich Mostert, Josef Braun, Matthew D Zimmerman

|Oct 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs.

Simon R Green, Susan H Davis, Sebastian Damerow

|May 31, 2022
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis.

Shuqi Li, Nicholas C Poulton, Jesseon S Chang

|Jan 05, 2021
Re-discovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis.

Heng Wang, Min Xu, Curtis A Engelhart

|Nov 02, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.

Tiago Beites, Kathryn O'Brien, Divya Tiwari

Pageof 2

Frequent Collaborators

5 joint publications

Dirk Schnappinger

3 joint publications

Helena I M Boshoff

3 joint publications

James Sacchettini

2 joint publications

Divya Tiwari